Narges Ghazi

Dr. Narges Ghazi


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Archives of Oral Biology
Verified
Journal Article
Closed access
NSNasrollah Saghravanian
Nasrollah Saghravanian
KAKazem Anvari
Kazem Anvari
NGNarges Ghazi
Narges Ghazi
BMBahram Memar
Bahram Memar
MSMaryam Shahsavari
Maryam Shahsavari
MAMonavar Afzal Aghaee
Monavar Afzal Aghaee

1 August 2014 in Annals of Diagnostic Pathology
Verified
Journal Article
Closed access
JSJahanshah Salehinejad
Jahanshah Salehinejad
NSNourieh Sharifi
Nourieh Sharifi
MAMaryam Amirchaghmaghi
Maryam Amirchaghmaghi
NGNarges Ghazi
Narges Ghazi
MSMohammad T Shakeri
Mohammad T Shakeri
AGAla Ghazi
Ala Ghazi

1 January 2011 in Journal of Oral Science
Verified
Journal Article
Open access
PDF file
JSJahanshah Salehinejad
Jahanshah Salehinejad
RZReza Zare-Mahmoodabadi
Reza Zare-Mahmoodabadi
SSShadi Saghafi
Shadi Saghafi
AJAmir-Hossien Jafarian
Amir-Hossien Jafarian
NGNarges Ghazi
Narges Ghazi
PMParviz Marouzi
Parviz Marouzi
Although ameloblastoma and adenomatoid odontogenic tumor (AOT) belong to the same group according to the World Health Organization, they show different biologic behaviors. PCNA, an amplifier of cell proliferation, and p53, a tumor suppressor protein, are overexpressed in some odontogenic lesions. The purpose of this study was to immunohistochemically evaluate the expression of p53 and PCNA to clarify the possible role of these proteins in different behaviors of ameloblastoma and AOT. The immunohistochemical expression of PCNA and p53 was determined in 30 solid ameloblastomas and 12 AOTs. Statistical tests including one-way ANOVA, t-test, chi-square, Mann-Whitney U and Kendall were used to analyze the data. All tissue sections (except one specimen of plexiform ameloblastoma) exhibited immunoexpression for p53. PCNA was expressed in all specimens. There was no significant difference in PCNA expression between ameloblastomas and AOTs (P > 0.05). For p53, there was no statistical difference between subtypes of ameloblastomas (P > 0.05), whereas statistical differences were observed between ameloblastomas and AOTs (P < 0.001). There was no statistical difference in PCNA intensity of staining between ameloblastomas and AOTs (P > 0.05), whereas the p53 intensity in ameloblastomas was stronger than AOTs (P < 0.05). Positive correlation between PCNA and p53 was observed. We concluded that PCNA overexpression is not responsible for the difference in clinical behavior of these two lesions, whereas the expression of p53 in ameloblastoma may explain the more aggressive nature of this tumor compared with AOT. (J Oral Sci 53, 213-217, 2011)

18 October 2023 in Annals of Diagnostic Pathology
Verified
Journal Article
Closed access
MMMajid Mirhashemi
Majid Mirhashemi
MSMasoumeh Sadeghi
Masoumeh Sadeghi
NGNarges Ghazi
Narges Ghazi
NSNasrollah Saghravanian
Nasrollah Saghravanian
MDMohsen Dehghani
Mohsen Dehghani
AAAmin Aminian
Amin Aminian

1 January 2010 in Journal of Oral Science
Verified
Journal Article
Open access
PDF file
NMNooshin Mohtasham
Nooshin Mohtasham
NMNasser Mahdavi-Shahri
Nasser Mahdavi-Shahri
JSJahanshah Salehinejad
Jahanshah Salehinejad
HEHamid Ejtehadi
Hamid Ejtehadi
MTMoluk Torabi-Parizi
Moluk Torabi-Parizi
NGNarges Ghazi
Narges Ghazi
Squamous cell carcinoma (SCC) is the most malignant neoplasm of the oral cavity. The mortality rate associated with head and neck cancers remains high, and thus detection techniques are important. In the present study, methyl green-pyronin staining was applied to 5 normal mucosa specimens, 10 cases of dysplastic mucosa, 12 cases of SCC (grade I), 10 cases of SCC (grade II) and 5 cases of SCC (grade III) in the oral cavity. This is the first study in which nuclear and nucleolar cytomorphometric parameters (diameter, area and number) in such oral lesions were evaluated using this method. As methyl green-pyronin selectively stains nucleic acids, it can differentiate between DNA (green) and RNA (red). The results reveal that the proposed method can be used to evaluate changes in the nucleus and nucleolus in premalignant lesions in the oral cavity. (J Oral Sci 52, 239-243, 2010)

10 November 2015 in Oman Medical Journal
Verified
Journal Article
Open access
NSNasrollah Saghravanian
Nasrollah Saghravanian
NGNarges Ghazi
Narges Ghazi
ZMZahra Meshkat
Zahra Meshkat
NMNooshin Mohtasham
Nooshin Mohtasham
Squamous cell carcinoma (SCC) is the most common oral malignancy, and verrucous carcinoma (VC) is a less invasive type of SCC. Leukoplakia (LP) is the most frequent premalignant lesion in the oral cavity. The human papillomavirus (HPV) has been recognized as one of the etiologic factors of these conditions. The association of anogenital and cervical cancers with HPV particularly its high-risk subtypes (HPV HR) has been demonstrated. The purpose of our study was to investigate the hypothetical association between HPV and the mentioned oral cavity lesions. One hundred and seventy-three samples (114 SCCs, 21 VCs, 20 LPs) and 18 normal mucosa samples (as a control group) were retrieved from the Department of Oral and Maxillofacial Pathology of Mashhad Dental School, Iran. The association of HPV genotypes in LP, VC, and SCC was compared to normal oral mucosa using the polymerase chain reaction. The results showed the absence of HPV in normal mucosa and LP lesions. In three samples of VC (14.3%), we observed the presence of HPV HR (types 16 and 18). All VCs were present in the mandibular ridge of females aged over 65 years old. No statistically significant correlation between HPV and VC was observed (p=0.230). Additionally, 15 (13.1%) SCCs showed HPV positivity, but this was not significant (p=0.830). The prevalence of SCC was higher on the tongue with the dominant presence of less carcinogenic species of HPV (types 6 and 11). A statistically significant association was not observed between HPV and SCC or VC in the oral cavity. More studies are necessary to better understand the relationship between HPV and malignant/premalignant oral cavity lesions.